Shares of Sanofi (NYSE:SNY) saw an uptick in trading volume on Tuesday . 7,489,941 shares traded hands during trading, an increase of 14% from the previous session’s volume of 6,589,197 shares.The stock last traded at $41.78 and had previously closed at $41.42.

A number of brokerages have recently issued reports on SNY. Zacks Investment Research cut Sanofi from a “buy” rating to a “hold” rating in a report on Monday, June 6th. JPMorgan Chase & Co. restated a “sell” rating on shares of Sanofi in a report on Monday, March 14th. Citigroup Inc. restated a “neutral” rating on shares of Sanofi in a report on Wednesday, April 27th. HSBC cut Sanofi from a “buy” rating to a “hold” rating in a report on Tuesday, May 3rd. Finally, Bank of America Corp. restated a “buy” rating and set a $58.00 price objective on shares of Sanofi in a report on Tuesday, May 3rd. Four analysts have rated the stock with a sell rating, six have given a hold rating and five have issued a buy rating to the company. Sanofi currently has an average rating of “Hold” and an average price target of $49.67.

The firm has a 50 day moving average of $40.47 and a 200-day moving average of $40.72. The firm has a market capitalization of $109.52 billion and a PE ratio of 23.21.

A number of large investors have recently bought and sold shares of the stock. Bank of Montreal Can raised its stake in Sanofi by 0.7% in the fourth quarter. Bank of Montreal Can now owns 389,519 shares of the company’s stock valued at $16,614,000 after buying an additional 2,560 shares during the period. Pinnacle Associates Ltd. raised its stake in shares of Sanofi by 2.2% in the fourth quarter. Pinnacle Associates Ltd. now owns 37,682 shares of the company’s stock valued at $1,607,000 after buying an additional 805 shares during the last quarter. PNC Financial Services Group Inc. raised its stake in shares of Sanofi by 1.5% in the fourth quarter. PNC Financial Services Group Inc. now owns 328,990 shares of the company’s stock valued at $14,032,000 after buying an additional 4,794 shares during the last quarter. Freestone Capital Holdings LLC bought a new stake in shares of Sanofi during the fourth quarter valued at about $1,672,000. Finally, TD Asset Management Inc. raised its stake in shares of Sanofi by 19.0% in the fourth quarter. TD Asset Management Inc. now owns 145,533 shares of the company’s stock valued at $6,091,000 after buying an additional 23,282 shares during the last quarter.

Sanofi SA is a healthcare company focused on patient needs and engaged in the research, development, manufacture and marketing of healthcare products. The Company is organized around three principal activities: Pharmaceuticals, Human Vaccines via Sanofi Pasteur, and Animal Health via Merial. The Company invests in emerging markets, diabetes solutions, vaccines, consumer health care, animal health, genzyme and other products.

Get Analysts' Upgrades and Downgrades Daily - Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.